.jpg)
The Latest in Critical Care, 8/21/23 (Issue #11)
PulmCCM
AUGUST 21, 2023
Performance was much higher for pneumococcal sepsis (which usually presents with more severe illness, rendering the biomarker less useful). A recent data analytic study examining procalcitonin’s use in 75,000 patients shows that it was only 68% sensitive at ruling out bloodstream infection, even at a low cutoff point of 0.5
88 
Let's personalize your content